Shandong Weigao boosts treasury holdings with latest share repurchase

Shandong Weigao Group Medical Polymer Company Limited (01066) repurchased 340,800 H shares on the Exchange on December 17, 2025, at prices ranging from HK$5.11 to HK$5.15, for an aggregate cost of HK$1,747,920. The repurchase represents a 0.0076% change in the number of issued shares (excluding treasury shares) before the event.

As a result of this transaction, the company's treasury shares increased from 30,582,800 to 30,923,600. The number of issued shares (excluding treasury shares) decreased from 4,491,749,524 to 4,491,408,724, while the total number of issued shares remained constant at 4,522,332,324.

The repurchase was made under a mandate granted on May 27, 2025, which authorized the company to repurchase up to 451,560,392 shares. To date, 24,275,200 shares have been repurchased on the Exchange or another stock exchange, representing 5.3758% of the issued shares (excluding treasury shares) as at the date of the resolution. A moratorium period for any new share issues or sales of treasury shares following this repurchase extends up to January 16, 2026.